

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Ko te Crizanlizumab he rongoā i hangaia hei āwhina i te hunga e mate ana i te mate pūtau kokopi ki te whakaiti i ā rātou raruraru mamae. Ka tukuna mā te whakauru IV i te whare hauora, te tikanga kotahi i te marama, ā, ka mahi mā te aukati i ngā pūtau toto kia piri tahi i roto i ō uaua toto.
Ko tēnei rongoā whāinga he taahiraa nui whakamua mō ngā tūroro mate pūtau kokopi e pā ana ki ngā wā mamae auau. Mā te aukati i tētahi pūmua motuhake e pā ana ki te pūtau toto kia piri tahi, ka āwhina te crizanlizumab i a koe kia iti ake ngā raruraru mamae, ā, ka pai ake pea tō kounga o te oranga.
Ko te Crizanlizumab he rongoā paturopi monoclonal e whāinga ana ki tētahi pūmua e kīia ana ko P-selectin i roto i ō uaua toto. Whakaarohia te P-selectin hei mata piri e pā ana ki te pūtau toto kia piri tahi, ka taea te aukati i te rere o te toto me te pā ki te mamae nui e pā ana ki ngā raruraru pūtau kokopi.
Ka hangaia te rongoā i raro i te ingoa waitohu Adakveo, ā, nō te akomanga rongoā e kīia ana ko te selectin blockers. I hangaia motuhake kia mōhio me te here ki te P-selectin, te whakakikorua i ēnei wāhi piri kia pai ake te rere o te pūtau toto mā ō uaua.
E whakaarohia ana tēnei he rongoā motuhake nā te mea me āta aroturuki me te whakahaere i roto i te taiao haumanu. Ka mahi tahi tō rōpū hauora me koe ki te whakatau mēnā ko te crizanlizumab te whiringa tika mō tō āhuatanga motuhake.
Ka whakamahia te Crizanlizumab i te tuatahi ki te whakaiti i te auau o ngā raruraru vaso-occlusive mamae i te hunga e mate ana i te mate pūtau kokopi. Ka pā ēnei raruraru i te wā e aukati ana ngā pūtau toto kokopi i ngā uaua toto, e pā ana ki te mamae nui ka roa mō ngā hāora, rānei ngā rā.
Kua whakaaetia te rongoa mō ngā pakeke me ngā tamariki 16 tau neke atu rānei, e pā ana ki ngā raruraru mamae e hoki mai ana. Kāore koe e hiahia ki te whai i tētahi tau motuhake o ngā raruraru i ia tau kia whai mana ai, engari ka whakaaro tō tākuta ki tō hītori mamae takitahi me te hauora whānui i te wā e whakatau ana mēnā e tika ana tēnei rongoā.
Ahakoa ka taea e te crizanlizumab te whakaiti i te auau o ngā raruraru, he mea nui kia mōhio koe kāore pea e whakakore i ngā wā katoa e mamae ana. He maha ngā tāngata e pā tonu ana ki ētahi raruraru, engari he iti ake te auau, ā, i ētahi wā he iti ake te kaha i mua i te rongoā.
Ka mahi a Crizanlizumab mā te aukati i te P-selectin, he pūmua e mahi ana pēnei i te velcro ngota i roto i ō uaua toto. I te wā e kaha ana te P-selectin, ka pā ana ki ngā pūtau toto, ngā pereti, me ētahi atu mea kia piri ki ngā pakitara o ngā uaua toto me tētahi ki tētahi.
I roto i te mate pūtau kokō, he raru nui tēnei tukanga piri, nā te mea kua hē kē ō pūtau toto whero, ā, he māmā te pōti. Mā te aukati i te P-selectin, ka āwhina a crizanlizumab ki te ārai i tēnei raruraru waka pūtau mai i te hanganga i te tuatahi.
E kiia ana he rongoā kaha tēnei i runga i tana mahi whāinga, engari ka mahi mā te ngawari i te roanga o te wā, kaua ki te whakarato i te āwhina tonu. Ka piki haere ngā pānga, koinei te take e hiahia ana koe ki ētahi whakaurunga i mua i te wheako i ngā painga katoa.
Ka hoatu a Crizanlizumab hei whakaurunga i roto i te uaua i roto i te 30 meneti i roto i te whare hauora. Ka whiwhi koe i te rongoā kotahi i ngā wiki e whā, ā, ka aroturuki tō rōpū hauora i a koe i te wā me muri i ia whakaurunga.
I mua i tō whakaurunga, ka hoatu pea ki a koe ngā rongoā i mua i te rongoā hei āwhina i te ārai i ngā tauhohenga pānga. Kei roto pea i ēnei ngā antihistamines, acetaminophen, corticosteroids rānei. Ka whakamōhio tō tākuta ki a koe mēnā e hiahia ana koe ki ēnei rongoā atu.
Kāore koe e hiahia ki te nohopuku i mua i te maimoatanga, ā, ka taea e koe te kai noa i ngā rā whakauru. Heoi, he pai te noho wai mā te inu i te wai nui i mua me muri i tō pōhiri. E kitea ana e ētahi tāngata he pai ki te kawe i tētahi paramanawa me tētahi mea hei pupuri i a rātou i te wā o te whakauru.
Ko te Crizanlizumab te tikanga he rongoā wā-roa ka haere tonu koe i te wā e āwhina ana ki te whakaiti i ō raruraru mamae, ā, kāore koe e pā ana ki ngā pānga taha e raruraru ana. Ko te nuinga o te tangata e noho ana i runga i te rongoā mō ngā marama, tau rānei.
Ka arotakehia e tō tākuta i ngā wā katoa te pai o te mahi o te rongoā mōu, te tikanga i muri i ngā marama tuatahi o te rongoā. Ka titiro rātou ki te maha o ngā raruraru mamae e pā ana ki a koe i te whakataurite ki mua i te tīmatanga o te crizanlizumab me te aroturuki i ngā pānga taha.
Ko te whakatau ki te haere tonu, ki te whakamutu rānei i te rongoā ka whakawhirinaki ki tō urupare takitahi me ngā huringa i tō hauora whānui. E hiahia ana ētahi tāngata ki te okioki i te rongoā mō tētahi wā poto mēnā ka whanake rātou i ngā mate, i ētahi atu take hauora rānei, engari he maha ka taea te haere tonu i te wā e pai ana rātou.
Pērā i ngā rongoā katoa, ka taea e te crizanlizumab te pānga taha, ahakoa he maha ngā tāngata e pai ana ki te tango. Ko ngā pānga taha noa he ngawari, he whakahaere i te tautoko hauora tika.
Koinei ngā pānga taha ka pā ki a koe, me te mahara kāore te katoa e whai i ēnei urupare:
Ngā pānga taha noa ko:
Ngā pānga taha kāore i te noa engari he nui ake te kino ko:
Ngā raruraru onge engari he nui te kino kei roto:
Ka mātakitaki tata tō rōpū hauora i a koe i te wā o ia whakaurunga, ā, ka whakaako rātou i a koe ki ngā tohu whakatūpato hei mātakitaki i te kāinga. Ko te nuinga o ngā pānga taha ka taea te whakahaere, ā, ko ngā painga o te whakaiti i ngā raruraru mamae ka nui ake i ēnei tūponotanga mō te nuinga o ngā tūroro.
Kāore a Crizanlizumab e tika ana mō te katoa, ā, ka āta arotake tō tākuta mēnā he haumaru mōu i runga i tō hītori hauora me tō āhua hauora o nāianei.
Kāore koe e tika kia whiwhi crizanlizumab mēnā he mate pāwera nui tō mohiotia ki te rongoā, ki ētahi o ōna wāhanga rānei. Ka tūpato anō tō tākuta mēnā he hītori tō koe mō ngā tauhohenga mate pāwera nui ki ētahi atu rongoā paturopi monoclonal.
Ko ngā tāngata e mate ana i ngā mate kino pea me tatari kia rongoatia te mate i mua i te tīmatanga o te crizanlizumab. Ka taea e te rongoā te raru ki te kaha o tō pūnaha ārai mate ki te whawhai i ngā mate, nō reira he mea nui te wā.
Me kōrero ngā wāhine hapū me te whāngai i ngā pēpi i ngā tūponotanga me ngā painga me ō rātou kaiwhakarato hauora, i te mea he iti noa ngā raraunga haumaru mō ēnei āhuatanga. Ka whakatau tō tākuta i ngā painga pea ki ngā tūponotanga pea ki a koe me tō pēpi.
Ka hokona a Crizanlizumab i raro i te ingoa waitohu Adakveo e Novartis Pharmaceuticals. Koinei anake te ingoa waitohu e wātea ana mō tēnei rongoā i te United States.
I te wā e whiwhi ana koe i tō rongoā, ka kite koe i te Adakveo i runga i te tapanga rongoā me ngā rēhita hauora. Kāore he momo rongoā whānui o te crizanlizumab e wātea ana i tēnei wā, he rongoā hou tonu kei raro i te whakamarumaru pātene.
Ko te inihua me ngā whakaritenga whakaaetanga i mua i te wā, ka tohutoro ki te ingoa whānui (crizanlizumab) me te ingoa waitohu (Adakveo) i roto i ā rātou tuhinga.
Ahakoa he ahurei te crizanlizumab i te āhua o tōna mahi, he rongoā anō e wātea ana hei āwhina i te whakahaere i te mate pūtau kokopi me te whakaiti i ngā raruraru mamae. Ka whakaaro pea tō tākuta i ēnei kōwhiringa kē mēnā kāore te crizanlizumab i te tika mōu.
Ko te Hydroxyurea te rongoā tuatahi mō te ārai i ngā raruraru pūtau kokopi. He rerekē tōna mahi i te crizanlizumab mā te whakanui i te hanga o te hemoglobin fetal, e āwhina ana i te ārai i ngā pūtau toto whero mai i te kokopi.
Ko te Voxelotor (Oxbryta) tētahi atu rongoā hou e mahi ana mā te whakanui i te kaha o te hemoglobin mō te hāora, e āwhina ana i te ārai i te kokopi. Ko te L-glutamine (Endari) he taapiri waikawa amino e āwhina ana i te whakaiti i te auau o ngā raruraru mā ngā tikanga rerekē.
Ka tūtohu pea tō tākuta i te rongoā whakakotahi, mā te whakamahi i te crizanlizumab me te hydroxyurea, ētahi atu rongoā rānei. Ka whakawhirinaki te whiriwhiri ki ō tohumate motuhake, te hītori hauora, me te pai o tō urupare ki ngā rongoā o mua.
He rerekē rawa ngā tikanga mahi o te crizanlizumab me te hydroxyurea, nō reira kāore i te māmā te whakataurite tika i a rāua. E rua ngā rongoā e whai hua ana ki te whakaiti i ngā raruraru mamae, engari ka pai ake pea mō ngā tāngata rerekē, i ngā āhuatanga rerekē rānei.
Kua whakamahia te Hydroxyurea mō ngā tekau tau, ā, he pai te pūkete haumaru, i te wā e hou ana te crizanlizumab, ā, he iti noa iho ngā raraunga mō te wā roa. Heoi anō, ko ētahi tāngata kāore i te pai te urupare ki te hydroxyurea ka kite pea i te painga nui mai i te crizanlizumab.
He maha ngā tākuta e whakamahi ana i ēnei rongoā ngātahi, kaua ki te kōwhiri i tētahi i runga i tētahi. I ētahi wā ka taea e te huarahi whakakotahi te whakarato i te aukati pai ake i te raru i te rongoā kotahi. Ka whakaarohia e tō tākuta tō hītori hauora takitahi, ngā urupare maimoatanga o mua, me ngā hiahia whaiaro i te wā e whakatakoto ana i ngā tūtohutanga.
Ka taea te whakamahi i te Crizanlizumab i te nuinga o te wā i roto i te hunga e mate ana i te mate tākihi ngawari ki te āhua, engari ka mātakitaki tata atu tō tākuta i a koe mēnā he raruraru tākihi tōu. Kāore te rongoā e whakakorea i te tuatahi mā ngā tākihi, nō reira kāore i te tika te whakatika i te horopeta.
Heoi anō, ko te hunga e mate ana i te mate pūtau kōpaka ka whakawhanake i ngā raruraru tākihi i te roanga o te wā, nō reira ka hiahia tō tākuta ki te aroturuki i tō mahi tākihi i ngā wā katoa ahakoa kei runga koe i te crizanlizumab. Ka tono pea rātou i ngā whakamātautau toto i te nuinga o te wā kia mōhio ai kei te pai te mahi o ō tākihi.
I te mea ka tukuna te crizanlizumab i roto i te taiao hauora whakahaere, he tino onge te nui rawa o te horopeta. Ka āta ine te rongoā, ā, ka whakahaerehia e ngā tohunga hauora whakangungu e whai ana i ngā tikanga tino kaha.
Mēnā e māharahara ana koe mō tō horopeta, ki te rānei ka pā mai ngā tohu rerekē i muri i te whakaurunga, whakapā atu ki tō kaiwhakarato hauora tonu. Ka taea e rātou te aromatawai i ō tohu, ā, ka whakarato i te manaakitanga tika mēnā e tika ana. Ka aroturukihia hoki koe e te pokapū whakaurunga mō ngā tohu o ngā tauhohenga kino i te wā me muri i te maimoatanga.
Mēnā ka ngaro koe i tō rārangi whakarite werohanga, whakapā atu ki tō kaiwhakarato hauora i te wa e taea ai ki te whakarite anō. He mea nui kia mau tonu tō rārangi maimoatanga kia pai ai te mahi o te rongoā.
I te nuinga o te wā, mēnā he rā torutoru noa iho koe i te mutunga, ka taea e koe te whiwhi i tō werohanga, ā, ka haere tonu ki tō rārangi marama. Heoi, mēnā kua ngaro koe i ngā horopeta maha, tērā pea ka hiahia tō tākuta ki te whakatika i tō mahere maimoatanga, ki te aroturuki rānei i a koe i te wā e tīmata anō ana koe.
Ko te whakatau ki te whakamutu i te crizanlizumab me mahi tonu i te taha o tō kaiwhakarato hauora. Kaua koe e whakamutu i te maimoatanga i runga i a koe anō, ahakoa kei te pai koe, kāore rānei koe i pā ki ngā raru mamae i ngā wā tata nei.
Ka arotakehia e tō tākuta i ngā wā katoa mēnā kei te whai hua tonu te maimoatanga mōu, i te nuinga o te wā i ia marama. Ka whakaarohia e rātou ngā āhuatanga pēnei i te maha o ngā raru mamae e pā ana ki a koe, ngā pānga taha e pā ana ki a koe, me ngā huringa i tō tūnga hauora whānui.
Ko te nuinga o ngā kano ārai mate he haumaru ki te whiwhi i te wā e tango ana i te crizanlizumab, engari me kōrero tonu koe i ngā kano ārai mate e haere ake nei ki tō kaiwhakarato hauora i te tuatahi. Tērā pea ka tūtohu rātou i ngā kano ārai mate i waenga i ngā werohanga, i te aroturuki rānei i a koe i muri i te kano ārai mate.
Tērā pea ka hiahia ngā kano ārai mate ora ki te whakaaro motuhake, i te mea ka pā te crizanlizumab ki tō urupare ārai mate. Ka arotakehia e tō tākuta tō hītori kano ārai mate me ngā hiahia o nāianei kia noho haumaru koe i ngā mate ka taea te ārai i te wā e rongoā ana koe.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.